Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedApr 24, 2019HCG 4,100 Units/vial InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1154-2019Class IITerminatedApr 24, 2019HCG 23 Day Injection Extra StrengthLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1153-2019Class IITerminatedApr 24, 2019HCG 20,000 units/vialLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1152-2019Class IITerminatedApr 24, 2019HCG 20 Day Extra StrengthLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1151-2019Class IITerminatedApr 24, 2019HCG 30 DayLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1150-2019Class IITerminatedApr 24, 2019HCG 23 DayLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1149-2019Class IITerminatedApr 24, 2019HCG 20 Day InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1148-2019Class IITerminatedApr 24, 2019HCG 11,000 UnitsLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1147-2019Class IITerminatedApr 24, 2019HCG 1,000 U/mL InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1146-2019Class IITerminatedApr 24, 2019Gentamicin 250 mg/1000 mL IrrigationLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1145-2019Class IITerminatedApr 24, 2019Gentamicin 120 mg/250 mL 0.9% Sodium Chloride for IrrigationLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1144-2019Class IITerminatedApr 24, 2019Estradiol Cypionate 10 mg/mLLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1143-2019Class IITerminatedApr 24, 2019DMSO 50% 60 mL/Heparin 1 mL/ Sodium Bicarbonate 60 mL/ Solu-Cortef 100 mgLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1142-2019Class IITerminatedApr 24, 2019Dexamethasone 24 mg/mL InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1141-2019Class IITerminatedApr 24, 2019Vancomycin 125 mg/3mL InhalationLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1140-2019Class IITerminatedApr 24, 2019Amphotericin B 0.15% Eye DropsLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1139-2019Class IITerminatedApr 24, 2019Atropine 0.01% Eye DropsLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1138-2019Class IITerminatedApr 24, 2019Acetylcysteine 10% Ophthalmic Eye Drop 2 mL droptainerLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1137-2019Class IITerminatedApr 24, 2019VolumexLack of Assurance of Sterility: environmental monitoring report exceeds limits, therefore sterility cannot be assured.Iso-Tex Diagnostics, Inc · D-1136-2019Class IITerminatedApr 24, 2019Divalproex Sodium Extended-Release TabletscGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.Dr. Reddy's Laboratories, Inc. · D-1133-2019Class IIITerminatedApr 24, 2019Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15Defective container: Ineffective seal between the cap and jar of the affected product.Estee Lauder Inc · D-1132-2019Class IITerminatedApr 24, 2019Dr. Berne's MSM DROPS 15% SolutionLack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.MSM Nutraceuticals, LLC · D-1129-2019Class IITerminatedApr 24, 2019Red Eye, Eye DropsLack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.MSM Nutraceuticals, LLC · D-1128-2019Class IITerminatedApr 24, 2019Dry Eye, Eye DropsLack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.MSM Nutraceuticals, LLC · D-1127-2019Class IITerminatedApr 24, 201915% MSM, Eye DropsLack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.MSM Nutraceuticals, LLC · D-1126-2019Class IITerminatedApr 24, 2019Testosterone Cypionate InjectionPresence of Particulate Matter.InvaGen Pharmaceuticals, Inc. · D-1125-2019Class IITerminatedApr 24, 2019Testosterone Cypionate InjectionPresence of Particulate Matter.InvaGen Pharmaceuticals, Inc. · D-1124-2019Class IITerminatedApr 24, 2019Testosterone Cypionate InjectionPresence of Particulate Matter.InvaGen Pharmaceuticals, Inc. · D-1123-2019Class ITerminatedApr 17, 2019Lidocaine HCl InjectionPresence of Particulate Matter: One vial was found to contain a hair.Aurobindo Pharma USA Inc. · D-1248-2019Class ITerminatedApr 17, 2019LEOPARD Miracle HoneyMarketed Without An Approved NDA/ANDA: product tainted with undeclared sildenafil, an FDA approved drug for the treatment of male erectile dysfunction. The presence of...USA LESS Inc. · D-1135-2019Class IIITerminatedApr 17, 2019Thallous Chloride TI 201 InjectionChemical Contamination: Trace amounts of an impurity was detected in the reagent used to manufacture finished product.Medi-Physics Inc. dba GE Healthcare · D-1134-2019Class IITerminatedApr 17, 2019Phenobarbital Oral SolutionLabeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.Lohxa LLC · D-1131-2019Class IITerminatedApr 17, 2019Bismuth Subsalicylate Oral Suspension 262mg/15mLLabeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.Lohxa LLC · D-1130-2019Class IIITerminatedApr 17, 2019Telmisartan and Amlodipine Tablets 80 mg/5 mgFailed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)AVKARE Inc. · D-1122-2019Class IIITerminatedApr 17, 2019Telmisartan and Amlodipine Tablets 80 mg/5 mgFailed Impurities/Degradation Specifications; 18 month long term stability study.Lupin Pharmaceuticals Inc. · D-1121-2019Class IITerminatedApr 17, 2019Pravastatin Sodium Tablets USPPresence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.Glenmark Pharmaceuticals Inc., USA · D-1120-2019Class IIOngoingApr 17, 2019Losartan Potassium / Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.Torrent Pharma Inc. · D-1119-2019Class IIOngoingApr 17, 2019Losartan Potassium / Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.Torrent Pharma Inc. · D-1118-2019Class IIOngoingApr 17, 2019Losartan Potassium / Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.Torrent Pharma Inc. · D-1117-2019Class IIOngoingApr 17, 2019LOSARTAN POTASSIUM TABLETSCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.Torrent Pharma Inc. · D-1116-2019